Neuberger Berman Group
EXAS

Neuberger Berman Group’s Exact Sciences EXAS Stock Holding History

Neuberger Berman Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-807,545
Closed -$82M – 2194
2025
Q4 		$82M Buy
807,545
+796,708
+7,352% +$64M 0.06% 355
2025
Q3 		$593K Sell
10,837
-3,330
-24% -$166K ﹤0.01% 1545
2025
Q2 		$753K Sell
14,167
-259
-2% -$13.2K ﹤0.01% 1449
2025
Q1 		$625K Sell
14,426
-2,065
-13% -$105K ﹤0.01% 1478
2024
Q4 		$927K Sell
16,491
-141,435
-90% -$8.8M ﹤0.01% 1336
2024
Q3 		$10.8M Sell
157,926
-115,471
-42% -$6.52M 0.01% 790
2024
Q2 		$11.6M Buy
273,397
+24,929
+10% +$1.37M 0.01% 749
2024
Q1 		$17.2M Buy
248,468
+233,517
+1,562% +$14.8M 0.01% 683
2023
Q4 		$1.11M Buy
14,951
+736
+5% +$48.2K ﹤0.01% 1260
2023
Q3 		$970K Sell
14,215
-602
-4% -$51.1K ﹤0.01% 1262
2023
Q2 		$1.39M Sell
14,817
-1,384
-9% -$108K ﹤0.01% 1166
2023
Q1 		$1.1M Buy
16,201
+463
+3% +$29.8K ﹤0.01% 1227
2022
Q4 		$779K Sell
15,738
-4,262
-21% -$174K ﹤0.01% 1313
2022
Q3 		$650K Sell
20,000
-5,604
-22% -$231K ﹤0.01% 1390
2022
Q2 		$1.01M Buy
25,604
+2,971
+13% +$159K ﹤0.01% 1278
2022
Q1 		$1.58M Sell
22,633
-565
-2% -$41.3K ﹤0.01% 1245
2021
Q4 		$1.79M Sell
23,198
-331,898
-93% -$29.3M ﹤0.01% 1225
2021
Q3 		$33.9M Buy
355,096
+31,507
+10% +$3.33M 0.03% 559
2021
Q2 		$40.2M Buy
323,589
+12,779
+4% +$1.53M 0.04% 524
2021
Q1 		$40.9M Buy
310,810
+25,089
+9% +$3.43M 0.04% 495
2020
Q4 		$37.9M Buy
285,721
+1,493
+0.5% +$181K 0.04% 471
2020
Q3 		$29M Buy
284,228
+24,905
+10% +$2.15M 0.03% 487
2020
Q2 		$22.5M Sell
259,323
-4,207
-2% -$336K 0.03% 540
2020
Q1 		$15.3M Sell
263,530
-26,373
-9% -$2.14M 0.02% 559
2019
Q4 		$26.8M Buy
289,903
+79,941
+38% +$7.03M 0.03% 531
2019
Q3 		$19M Buy
209,962
+5,376
+3% +$613K 0.02% 593
2019
Q2 		$24.1M Buy
204,586
+4,780
+2% +$482K 0.03% 551
2019
Q1 		$17.3M Buy
199,806
+162,855
+441% +$13.9M 0.02% 634
2018
Q4 		$2.33M Sell
36,951
-933
-2% -$64K ﹤0.01% 955
2018
Q3 		$2.99M Buy
37,884
+922
+2% +$60.1K ﹤0.01% 979
2018
Q2 		$2.21M Buy
36,962
+20,814
+129% +$1.12M ﹤0.01% 1044
2018
Q1 		$651K Buy
+16,148
New +$788K ﹤0.01% 1304
2017
Q4 		– Sell
-266,433
Closed -$12.6M – 1770
2017
Q3 		$12.6M Sell
266,433
-287,537
-52% -$11.6M 0.02% 714
2017
Q2 		$19.6M Buy
553,970
+283,406
+105% +$8.75M 0.03% 609
2017
Q1 		$6.39M Buy
+270,564
New +$5.36M 0.01% 820

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Neuberger Berman Group's EXAS Position: Q1 2026 in Review

Neuberger Berman Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 807,545 shares — an estimated $82M sold.

Neuberger Berman Group first reported a position in EXAS in Q1 2017 and held it in 35 quarters. The position peaked at $82M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Neuberger Berman Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Neuberger Berman Group sold 807,545 Exact Sciences shares in Q1 2026, an estimated $82M.
  • Neuberger Berman Group first reported a position in Exact Sciences in Q1 2017 and held it in 35 quarters.
  • Neuberger Berman Group's Exact Sciences position peaked at $82M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.